Literature DB >> 29707309

Prognostic value of pre-transplant mean pulmonary arterial pressure in lung transplant recipients: a single-institution experience.

Chi Young Kim1, Ji Eun Park1, Ah Young Leem1, Joo Han Song1, Song Yee Kim1, Kyung Soo Chung1, Eun Young Kim1, Ji Ye Jung1, Young Ae Kang1, Young Sam Kim1, Joon Chang1, Jin Gu Lee2, Hyo Chae Paik2, Moo Suk Park1.   

Abstract

BACKGROUND: Currently, lung transplantation (LTX) is considered to be a curative treatment option in patients with end-stage lung disease. Although pulmonary hypertension (PH), confirmed by cardiac catheterization, is a prognostic factor in patients undergoing LTX, the prognostic value of PH in Asian lung transplant recipients remains uncertain. In this study, we aimed to determine whether PH before LTX may serve as a prognostic factor for survival in Asian patients.
METHODS: The medical records of 50 patients [male, 27; female, 23; mean age, 51.0 (41.0-60.0) years], who received preoperative right heart catheterization (RHC) and echocardiography before single or double LTX at Severance Hospital between January 2010 and December 2014, were reviewed. The relationship between 1-year survival after LTX and PH [mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest] was evaluated.
RESULTS: The mean right ventricular systolic pressure and mPAP were 48.5 (22.8) and 30.0 (24.0-40.0) mmHg. Of the 50 patients, 17 (34.0%) died within a year after LTX. The 1-year survival rate among patients with mPAP ≥25 mmHg (58.8%) was lower than the survival rate among patients with mPAP <25 mmHg (87.5%). Pre-transplantation mPAP of ≥25 mmHg was associated with post-transplantation survival [hazard ratio (HR), 4.832; 95% confidence interval (CI), 1.080-21.608, P=0.039]. The presence of preoperative PH was also associated with an increased risk of postoperative complications.
CONCLUSIONS: Confirmation of PH via preoperative cardiac catheterization was associated with the prognosis of the patient after LTX. Clinicians should consider the necessity for early transplantation surgery before the mPAP reaches ≥25 mmHg.

Entities:  

Keywords:  Lung transplantation (LTX); hypertension; prognosis; pulmonary

Year:  2018        PMID: 29707309      PMCID: PMC5906309          DOI: 10.21037/jtd.2018.03.46

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  40 in total

1.  Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  Christopher J Lettieri; Steven D Nathan; Scott D Barnett; Shahzad Ahmad; Andrew F Shorr
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

2.  Influence of pulmonary hypertension on survival in advanced lung disease.

Authors:  Don Hayes; Sylvester M Black; Joseph D Tobias; Heidi M Mansour; Bryan A Whitson
Journal:  Lung       Date:  2015-02-18       Impact factor: 2.584

3.  Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease.

Authors:  Vikas K Singh; M Patricia George; Cynthia J Gries
Journal:  J Heart Lung Transplant       Date:  2015-01-24       Impact factor: 10.247

4.  Risk factors predictive of one-year mortality after lung transplantation.

Authors:  Anton Sabashnikov; Alexander Weymann; Prashant N Mohite; Bartlomiej Zych; Nikhil P Patil; Diana García Sáez; Aron-Frederik Popov; Mohamed Zeriouh; Thorsten Wahlers; Thorsten Wittwer; Jens Wippermann; Fabio De Robertis; Toufan Bahrami; Mohamed Amrani; André R Simon
Journal:  Eur J Cardiothorac Surg       Date:  2014-10-23       Impact factor: 4.191

5.  Prognostic value of RV function before and after lung transplantation.

Authors:  Kenya Kusunose; Rayji S Tsutsui; Kavita Bhatt; Marie M Budev; Zoran B Popović; Brian P Griffin; Michael A Bolen
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-10

6.  [ESC guidelines 2015 pulmonary hypertension: diagnosis and treatment].

Authors:  Christian Opitz; Stephan Rosenkranz; Hossein Ardeschir Ghofrani; Ekkehard Grünig; Hans Klose; Horst Olschewski; Marius Hoeper
Journal:  Dtsch Med Wochenschr       Date:  2016-11-30       Impact factor: 0.628

7.  Weight loss prior to lung transplantation is associated with improved survival.

Authors:  Satish Chandrashekaran; Cesar A Keller; Walter K Kremers; Steve G Peters; Matthew A Hathcock; Cassie C Kennedy
Journal:  J Heart Lung Transplant       Date:  2014-11-17       Impact factor: 10.247

8.  Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.

Authors:  Motohiro Kimura; Hiroyuki Taniguchi; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Osamu Nishiyama; Hiromichi Aso; Koji Sakamoto; Yoshinori Hasegawa
Journal:  Respiration       Date:  2012-12-19       Impact factor: 3.580

9.  Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation.

Authors:  Don Hayes; Sylvester M Black; Joseph D Tobias; Heidi M Mansour; Bryan A Whitson
Journal:  COPD       Date:  2015-09-14       Impact factor: 2.409

10.  Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant.

Authors:  A F Shorr; J L Wainright; C S Cors; C J Lettieri; S D Nathan
Journal:  Eur Respir J       Date:  2007-07-11       Impact factor: 16.671

View more
  3 in total

Review 1.  Critical Care before Lung Transplantation.

Authors:  Jin Gu Lee; Moo Suk Park; Su Jin Jeong; Song Yee Kim; Sungwon Na; Jeongmin Kim; Hyo Chae Paik
Journal:  Acute Crit Care       Date:  2018-11-30

2.  Accuracy of echocardiography and chest tomography for pulmonary hypertension screening in patients awaiting lung transplantation.

Authors:  Luiza Helena Degani-Costa; João Paulo de Assis; Pedro Paulo Pisaniello Gonçalves; Fernanda Gushken; Gilberto Szarf; José Eduardo Afonso Junior
Journal:  Einstein (Sao Paulo)       Date:  2021-12-20

3.  Recipient Comorbidities for Prediction of Primary Graft Dysfunction, Chronic Allograft Dysfunction and Survival After Lung Transplantation.

Authors:  Jonas Peter Ehrsam; Macé M Schuurmans; Mirjam Laager; Isabelle Opitz; Ilhan Inci
Journal:  Transpl Int       Date:  2022-06-29       Impact factor: 3.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.